- Durham, NC
Chimerix is a biotechnology company developing therapeutics for antiviral diseases.
Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health.
The companyâ€™s lead candidate, CMX001, is being developed as a potential broad spectrum antiviral agent for the treatment of life-threatening double-stranded DNA (dsDNA) viral diseases. Over 350 people have received CMX001 to date, with a growing body of evidence supporting the drugâ€™s antiviral activity in humans.
Clinical studies of CMX001 include an ongoing Phase 2 study of the prevention/control of cytomegalovirus (CMV) in hematopoietic stem cell transplant patients (CMX001-201), a Phase 2 study being initiated for the treatment of adenovirus (AdV) infection in pediatric and adult hematopoietic stem cell transplant patients (CMX001-202), and an Open-Label Study (CMX001-350) for the treatment of any of 12 different dsDNA viral... See More
Current Team (3)Update
Board Members and Advisors (5)Update
Funding Rounds (4) - $95.20MUpdate
Asset Management Company is a Silicon Valley venture capital firm. Since 1965, the company has..
Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in..
Oldest investment firms
IT and Healthcare VC
Frazier Technology Ventures is a Seattle-based venture capitalist firm focused on investments in..
At Pappas Ventures, their sole focus is investing in the life sciences â€“ biotechnology,..
Health-Care Focused VC Firm
Founded in 1991, Frazier Healthcare Ventures is one of the leading providers of venture and growth..
2505 Meridian Parkway
Durham, NC 27713